Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche

Three More Drug Makers Top Earnings Expectations in Q2


Today three more price-gouging Big Pharma companies reported better-than-expected earnings in Q2 and raised forecasts for the rest of the year — after engaging in a frenzy of price hikes this year.



These Big Pharma giants have all continued to hike prices on the drugs in their portfolios, continuing to put profits over people, even as one in four Americans struggle to afford their medications.



With Big Pharma continuing to live the high life while price-gouging American patients, policymakers in Washington need to act now, more than ever, to hold the industry accountable.

A trend has begun to emerge. So far Johnson & Johnson, Novartis and GlaxoSmithKline have also beat earnings expectations in Q2. Tomorrow we’ll see if AbbVie closes out the week on the same note.


Sign-up for updates

  • This field is for validation purposes and should be left unchanged.